Application of recombinant antibodies for treatment of Clostridioides difficile infection: Current status and future perspective

Overview of attention for article published in Frontiers in immunology, August 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 27 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 10 publications that cite this research output.

10

The most recent citing publications are shown below. View all 10 publications that cite this research output on Dimensions.

PhosphoLipidome Alteration Induced by Clostridioides difficile Toxin B in Enteric Glial Cells

Article in Cells (June 2024)

Phage display technology and its impact in the discovery of novel protein-based drugs

Article in Expert Opinion on Drug Discovery (June 2024)

The anti-inflammatory and anti-apoptotic effects of Achillea millefolium L. extracts on Clostridioides difficile ribotype 001 in human intestinal epithelial cells

Article in BMC Complementary Medicine and Therapies (January 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.